Paradigm BioCapital Advisors LP 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-24 4:00 pm Purchase | 2026-02-17 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Paradigm BioCapital Advisors LP | 4,192,261 5.100% | 4,192,261 (New Position) | Filing |